News
SSRI medications have come under scrutiny as of late, despite medical experts maintaining they're safe and effective.
Axsome Therapeutics, Inc.’s AXSM share price has dipped by 8.23%, which has investors questioning if this is right time to ...
Summary: Duloxetine is a balanced selective serotonin and norepinephrine-reuptake inhibitor available in the United States for the treatment of major depressive disorder (MDD) and diabetic ...
Medication. Antidepressants usually prescribed for depression, according to NYU Langone Health, include selective serotonin ...
Serotonin-norepinephrine reuptake inhibitors are very similar to SSRIs in that they’re also responsible for increasing serotonin levels. However, they double up by targeting a neurotransmitter ...
Unlike traditional stimulant medications, which primarily increase dopamine levels through direct release, solriamfetol is a dopamine and norepinephrine reuptake inhibitor (DNRI) with additional ...
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) are indicated for the conditions listed for SSRIs but are a bit more activating, which is an advantage for the depressed patient who feels ...
Among patients with narcolepsy, AXS-12 (reboxetine) vs placebo significantly reduced the frequency of cataplexy attacks.
or serotonin-norepinephrine reuptake inhibitor (SNRI). During the double-blind treatment phase, patients were randomly assigned to receive aticaprant 10mg or placebo once daily, in addition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results